Recent Finacing
Recent Raise
Aminex Therapeutics, based in Kirkland, Washington, develops suppressor cell modulator small-molecule cancer immunotherapies targeting myeloid-derived suppressor cells; lead candidate AMX-513 progressed through preclinical studies toward Phase 1/2a preparation.
Focus Areas
Total Raised
Funding round